Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review

SIMPLE SUMMARY: For decades, there has been no globally accepted neoadjuvant or adjuvant therapy in resectable biliary tract cancer. Based on the results of the BILCAP trial, adjuvant capecitabine has been widely regarded as standard adjuvant therapy. Focusing on the management of resectable biliary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Yoo, Changhoon, Shin, Sang Hyun, Park, Joon-Oh, Kim, Kyu-Pyo, Jeong, Jae Ho, Ryoo, Baek-Yeol, Lee, Woohyung, Song, Ki-Byung, Hwang, Dae-Wook, Park, Jin-hong, Lee, Jae Hoon
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8037230/
https://ncbi.nlm.nih.gov/pubmed/33916008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071647
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados